The Westminster Park Plaza Hotel is the venue for both events.
The Congress and Summit are hosted by King's College London and are organized in partnership with world-leading diabetes organizations. Two seminal events in one, the congress is an unprecedented gathering to review the latest research in metabolic surgery and to develop new guidelines for the development of a modern, multi-modality approach to the care of type 2 diabetes.
The event will examine the significant role of bariatric/metabolic surgery in improving the management and understanding of type 2 diabetes. A comprehensive review of the science behind this approach will include the latest results of long-term randomized clinical trials, including late-breaking studies presented for the first time and the newest findings on the fascinating mechanisms of action in metabolic surgery.
Clinical Sessions will also feature a comprehensive review and discussion of the latest studies on the effects of surgery on glycemic control and cardiovascular risk in patients with T2DM, including in those with lower BMI and in adolescents. Scientists will also review current evidence on the functioning of the gastrointestinal tract and its role in the physiology and pathophysiology of glucose homeostasis.
"The advanced scientific program will be coupled with an unparalleled opportunity for attendees to participate in the evaluation of new guidelines and recommendations for the surgical treatment of diabetes," comments Prof. Francesco Rubino, MD, Congress Chair, Chair, Bariatric and Metabolic Surgery King's College London.
"Attending the 3rd World Congress & DSS-II is a unique opportunity to be a part of and witness history and we invite medical professionals and clinicians to join the world's leading experts and policy makers in this ground-breaking endeavor. More importantly, this is not a specialized surgical conference nor an endocrinology conference, but rather the only forum in the world that brings together physicians, surgeons, basic scientists, industry leaders, and policy makers, while also representing the perspective of patients," he added.
Prof. David e. Cumming, DSS Co-Director, Division of Metabolism, Endocrinology and Nutrition, University of Washington, states "Cutting-edge evidence related to bariatric/metabolic surgery will be presented and used to generate new, modern guidelines for the use and study of gastrointestinal surgery to treat diabetes, obesity, and other metabolic diseases. We welcome you to witness and participate in this historic event".
The 3rd World Congress was established to address the challenges and seize the opportunities that surgery offers to diabetes care and research. It is an international forum where a faculty of clinicians, scientists, and policy makers discuss available evidence on the use and study of bariatric/metabolic surgery and new device-based intervention.
The overarching aim of the congress is to craft an agenda of research priorities and health policy initiatives. The consensus portion of the meeting (DSS-II) will be attended by global policy-makers and organized in partnership with the American Diabetes Association (ADA), the European Society for the Study of Diabetes (EASD), the International Diabetes Federation (IDF), Diabetes UK, Chinese Diabetes Society and Diabetes India.
To register and for more information, visit the congress website: www.wcitt2d.org.
No comments:
Post a Comment